The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

Reports of COVID-19-associated mucormycosis have been increasing in frequency since early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes and hyperglycaemia often have an inflammatory state that could be potentiated by the activation of antiviral immunity to SARS...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Lancet. Microbe 2022-07, Vol.3 (7), p.e543-e552
Hauptverfasser:	Hoenigl, Martin, Seidel, Danila, Carvalho, Agostinho, Rudramurthy, Shivaprakash M, Arastehfar, Amir, Gangneux, Jean-Pierre, Nasir, Nosheen, Bonifaz, Alexandro, Araiza, Javier, Klimko, Nikolai, Serris, Alexandra, Lagrou, Katrien, Meis, Jacques F, Cornely, Oliver A, Perfect, John R, White, P Lewis, Chakrabarti, Arunaloke
Format:	Artikel
Sprache:	eng
Schlagworte:	COVID-19 - complications Diabetes Mellitus - epidemiology Humans Life Sciences Mucormycosis - complications Review Risk Factors RNA, Viral SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!